Carregant...
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Abstract Nanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer. Nanoparticles can either passively accumulate within tumour sites, or be conjugated with targeting ligands to actively enable tumour deposition. With respect to passive accumulation...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2018-11-01
|
| Col·lecció: | Cancer Nanotechnology |
| Matèries: | |
| Accés en línia: | http://link.springer.com/article/10.1186/s12645-018-0044-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|